<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Edinburgh_OG_Results_Lambda skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Edinburgh OG/Results/Lambda</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>PhagED: a molecular toolkit to re-sensitise ESKAPE pathogens</TITLE></P><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><NAV class="collapse navbar-collapse navbar-right" role="navigation"><DIV class="main-menu"><UL class="nav navbar-nav navbar-right"><LI><A href="https://2017.igem.org/Team:Edinburgh_OG">Home</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG#team">Team</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Project </A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Description">Description</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Model">Model</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Experiments">Experiments</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Notebook">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Collaborations">Collaborations</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/InterLab">Interlab</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Attributions">Attributions</A></LI></UL></DIV><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Design</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Design">Design</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Applied_Design">Applied Design</A></LI></NAV></DIV><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Parts</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Basic_Part">Basic Parts</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Improve">Improve</A></LI></DIV><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/Safety">Safety</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/HP/Silver">Silver HP</A></LI><LI><A href="https://2017.igem.org/Team:Edinburgh_OG/HP/Gold_Integrated">Integrated Gold</A></LI></DIV><LI><A href="https://2017.igem.org/Team:Edinburgh_OG#call-to-action">Contact</A></LI><LI class="medals"><A href="https://2017.igem.org/Team:Edinburgh_OG/Medals">Medals</A></LI></DIV></DIV><DIV class="column full_size"><A class="btn-back" data-wow-delay=".9s" href="https://2017.igem.org/Team:Edinburgh_OG/Results" style="visibility: visible; animation-delay: 0.9s;">Back to results</A><H1 class="subtitle text-center">Production of Lambda phage with SaCas9/FnCpf1</H1><P>To introduce the CRISPR systems into &amp;lambda, both SaCas9 and FnCpf1 were separately inserted into the P1 phagemid and then digested/ligated with the &amp;lambda using BsiWI and AvrII. Electroporation was used to introduce the engineered λ (SaCas9-λ and FnCpf1-λ) into our testing <EM>E. coli </EM>platform (MoClo). The production of engineered phages required a long period during which the electroporation was tested and optimised. The electroporation test performed in <EM>E. coli</EM> with the pGEX-4T-1 plasmid was successful and we moved to the optimisation step. The technique was optimised by separately varying the voltage, incubation period, exposure time, media but none of them resulted in an optimisation of the technique. During the electroporation optimisation with λ (not engineered), a single plaque was found in different replicates/optimisation steps (Figure 1) suggesting the inconsistency of the technique. When performing the electroporation with both the engineered λ, no viable recombinant phages were obtained and this part of the project could not be completed. The overall failure of the electroporation was probably due to the presence of active restriction systems in <EM>E. coli</EM> JM1 which destroyed the λ genome upon infection. Moreover, λ purchased was produced from a different strain of <EM>E. coli </EM>(GM33). Phages are sensible to the change of host and different chassis can be incompatible. Finally, the JM1 strain carries several mutations which make this strain fragile thus hindering the capability to uptake DNA and produce exogenous proteins.</P><DIV class="div-fig" style="width:800px;"><P><STRONG>Figure 1: </STRONG>Electroporation optimisation: only one plaque (red circle) was found in two conditions (1.5 kV - plate 1- and 1.75 kV - plate 2)</P></DIV><H1 class="subtitle text-center">Want more results?</H1></DIV></DIV></BODY></HTML>